Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke

NCT01133223 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Stroke

Interventions

DEVICE: Penumbra™ System
DRUG: Recombinant tissue plasminogen activator

Sponsor

Hospital de Clinicas de Porto Alegre